Logo image
Progress and Prospects: prospects of repeated pulmonary administration of viral vectors
Journal article   Peer reviewed

Progress and Prospects: prospects of repeated pulmonary administration of viral vectors

P. L SINN, E. R BURNIGHT and P. B MCCRAY
Gene therapy, Vol.16(9), pp.1059-1065
2009
DOI: 10.1038/gt.2009.87
PMID: 19641533
url
https://www.ncbi.nlm.nih.gov/pmc/articles/4376355View
Open Access

Abstract

Pulmonary gene therapy may ultimately cure diseases such as cystic fibrosis, α1-antitrypsin deficiency, lung cancer and pulmonary hypertension. Efficient expression of delivered genes in target cell types is essential for the achievement of this goal. To this end, re-administration of viral vectors may be required (1) to increase the percentage of transduced airway epithelial cells, (2) to direct gene transfer to individual lobes during successive delivery sessions or (3) to boost attenuated expression over time. Immune responses to viral proteins or viral-encoded proteins are the greatest barrier to repeated vector administration.
Biotechnology Gene Therapy Fundamental and applied biological sciences. Psychology Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Health. Pharmaceutical industry Industrial applications and implications. Economical aspects Transfusions. Complications. Transfusion reactions. Cell and gene therapy Applied cell therapy and gene therapy Biological and medical sciences Medical sciences

Details

Metrics

Logo image